Introduction
According to WHO, dementia is a progressive neurodegenerative syndrome that affects approximately 50 million people worldwide, with 10 million new cases diagnosed each year.1 The heterogeneous syndrome may be characterised by decrements in cognitive abilities that significantly impede independent, daily functioning. Among the different variants of dementia, Alzheimer’s disease (AD) and vascular dementia are the most prevalent subtypes, accounting for 60% to 80% of all cases.2 Recognised as a leading cause of disability, dementia impacts the individual’s quality of life and well-being, and may further place burden on family, community and the healthcare system. In 2016, the global economic cost of dementia reached US$948 billion,3 a cost that continues to rise in the context of an ageing population.
There is currently no cure for dementia and available treatments for AD and other dementias are minimally effective at best. Consequently, the examination of lifestyle behaviours that may prevent or delay dementia has surged in the last two decades. Indeed, epidemiological analyses of cognitive trajectory in later adulthood suggest that declineing in cognitive function is largely dependent on modifiable lifestyle behaviours.4 5 Nutrient intakes and nutraceuticals have gained increasing attention over the last decade as potential effect modifiers in the risk of cognitive impairment.6 7 More recently, the benefits of tea consumption for cognitive health in later adulthood has been investigated.
Next to water, tea (aka, Camellia sinensis (L.)) is the most frequently consumed beverage around the world. Although null associations have been reported in some studies,8 epidemiological studies suggest that tea consumption may decrease the risk of cognitive impairment and dementia.9 10 In a meta-analysis of 17 studies investigating the association between tea consumption (green, black/oolong) and the risk of cognitive disorders, it was found that high tea consumption was associated with a reduced risk of cognitive disorders. Furthermore, dose-response analyses of eight studies suggest a dose response in reduced risk from 100 mL/day (6% reduced risk) to 300 mL/day (19% reduced risk), and 500 mL/day (29% reduced risk) of tea consumption.11
Although the exact mechanism remains elusive, multiple bioactive components of tea that may modulate neuronal function have been identified. Tea polyphenols, especially epigallocatechin gallate, have been shown to hold anti-oxidative, anti-inflammatory and neuroprotective properties. Furthermore, theanine has been shown to impart neuroprotective effects through its regulatory effects on glutamate, which is vital for learning and memory. A third bioactive component, notably found in black tea, are theaflavins. Theaflavins have been shown to offer neuroprotective effects through its antioxidant and anti-apoptosis properties.12 Accordingly, tea consumption may protect cognitive processes in late life through various mechanisms of action.
To date, studies examining the benefit of tea consumption on brain health have focused on the prediction of cognitive impairment; however, few studies have examined the association between tea consumption and the performance on specific tasks of cognitive function. In a sample of 712 non-demented Chinese participants aged 55 or older, it was found that tea consumers performed better on tasks of memory and executive function, relative to non-consumers.13 However, this study excluded persons who displayed cognitive impairment and were indexed by a score of <24 on the Mini-mental State Examination.13 As such, the relationship between tea consumption and cognitive performance among older adults with cognitive impairment is unknown.
The objective of this study was to investigate the association between tea consumption and cognitive performance among cognitively healthy (CH) older adults and older adults with mild cognitive impairment (MCI). Based on previous research, it was hypothesised that tea consumption would associate with better performance on cognitive tasks of episodic memory and working memory. It was also hypothesised that this association would be observed among older adults with MCI.